Goldman Sachs, AbbVie And A Major Chipmaker: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners said Taiwan Semiconductor Manufacturing Company Limited TSM goes higher.

Taiwan Semiconductor Manufacturing is reportedly eyeing its second Japanese plant in the same town as its first in Kumamoto prefecture. The critical Apple and Nvidia supplier looks to make a formal announcement on the location of its second factory in February, Nikkei Asia cited farm minister Tetsushi Sakamoto, the House of Representatives lawmaker.

Bill Baruch of Blue Line Futures picked AbbVie Inc. ABBV, which is scheduled to release earnings on Friday.

William Blair analyst Tim Lugo upgraded AbbVie from Market Perform to Outperform, noting confidence in the company’s growth outlook over the near and long term as it heads into 2024. AbbVie is set to release its fourth quarter 2023 earnings on Feb. 2, 2024. According to data from Benzinga Pro, the company is expected to report an EPS of $2.81 with sales of $14.03 billion.

Don’t forget to check out our premarket coverage here

Joe Terranova of Virtus Investment Partners named The Goldman Sachs Group, Inc. GS as his final trade.

Goldman Sachs is reportedly seeking new talent for its asset and wealth management divisions as part of its ongoing efforts to grow these sectors. The bank’s fourth-quarter earnings received a boost from the growth of these units, with revenue from the divisions surging by 23%, surpassing estimates, Bloomberg reported.

Price Action:

• Taiwan Semiconductor Manufacturing shares fell 0.2% to close at $116.98 on Monday.
• Shares of AbbVie fell 0.3% to close at $163.91 on Monday.
• Goldman Sachs shares gained 0.7% to settle at $380.56 during Monday’s session.

Check This Out: Insiders Buying Compass Minerals International And 2 Other Stocks

Photo: Shutterstock